Aker BioMarine receives FDA approval for its QRILL Aqua in US

FDA has approved it for use in salmon feeds

Aker BioMarine has received approval from the Food and Drug Administration (FDA) for the use of its QRILL Aqua and QRILL High Protein (QHP) products in freshwater and marine salmonids. Thereby, the US salmon farming industry can now benefit from the nutritional benefits of krill.

Consequently, this is a great achievement for Aker BioMarine and the fish farming industry. It is remarkable for the salmon industry in the US to obtain access to sustainable, safe, and highly nutritious ingredients for their feeds.

Regarding this, Sigve Nordrum, EVP of Animal Health, and Nutrition of Aker BioMarine said: "For years, feed companies and fish farmers in this region were well aware of the benefits of krill for fish feeds and salmon. Therefore they have been demanding these products for their North American operations."

"We look forward to working with our customers in this market. To support the production of high quality, sustainable and healthy fish," he added.

QRILL Aqua functions as a feeding stimulant leading to increased feed uptake and enhanced growth. Antarctic krill is the source and improves health, stress tolerance, and fillet quality.

On the other hand, QHP is a protein-rich product used in formulated diets for aquaculture nutrition. It is an excellent source of marine protein for fish and shrimp, leading to increased feed uptake and enhanced growth.

About Aker BioMarine

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Aker BioMarine's fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world.